
    
      Study MI-CP199, a Phase 2a, randomized, double-blind, placebo-controlled, parallel-arm,
      multicenter study will evaluate the effect of 3 SC treatment regimens of CAT-354 on asthma
      control in adults with uncontrolled, moderate-to-severe, persistent asthma.
    
  